Response to Comments: Treatment of Males with Low Testosterone

This is a response-to-comments notice regarding LCD L39086 (Treatment of Males with Low Testosterone); no comments were received during the comment period. The notice period begins 2021-12-30 and the LCD is effective 2022-02-13. The document contains no coverage criteria—refer to LCD L39086 for the specific indications, limitations, documentation, and frequency rules.

"This document is a response-to-comments notice for Local Coverage Determination L39086 (Treatment of Males with Low Testosterone); no public comments were received; notice period begins 2021-12-30 ..."

Sign up to see full coverage criteria, indications, and limitations.